SCHEMBL6142920

SCHEMBL6142920

COc1ccc(CNN2CCC(O)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
PKM P14618 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CCNE2 O96020 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
GRM3 Q14832 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
CYP3A4 P08684 1/20 0.43
KDM1A O60341 1/20 0.43
CYP2D6 P10635 1/20 0.43
CXCR4 P61073 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151064 0.91 MEN1 (0.46) ALDH1A1PKMMEN1KMT2ACCNE2
SCHEMBL22553711 0.85 SIGMAR1 (0.50) ALDH1A1PKMMEN1KMT2ASMN1; SMN2
SCHEMBL2390775 0.76 MEN1 (0.68) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL26100694 0.75 MCHR1 (0.59) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL6142919 0.74 GRM3 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL17182961 0.74 CXCR4 (0.54) ALDH1A1PKMMEN1KMT2ASMN1; SMN2
SCHEMBL15718995 0.74 CXCR4 (0.54) ALDH1A1PKMMEN1KMT2ASMN1; SMN2
SCHEMBL15718994 0.74 CXCR4 (0.54) ALDH1A1PKMMEN1KMT2ASMN1; SMN2
SCHEMBL24515858 0.73 ALDH1A1 (0.45) ALDH1A1PKMSMN1; SMN2RAB9ANPC1
SCHEMBL28912432 0.72 KMT2A (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021186-B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha CV THERAPEUTICS INC (US) 2005-06-29 EP disclosed